Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

Circulation

Volumn 97, Issue 13, 1998, Pages 1234-1238

  Sorensen, Keld E ^a   Dorup, Inge ^a   Hermann, Anne P ^a   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cholesterol; Endothelium; Hormones; Ultrasonics; Women

Indexed keywords

ESTROGEN; PROGESTERONE; TRISEQUENS;

ADULT; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY RISK; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME; VASOMOTOR REFLEX;

EID: 0032492744     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.13.1234     Document Type: Article

References (41)

1. Barrett-Connor E, Bush TL. Estrogens and coronary heart disease. JAMA. 1991;265:1851-1867.
2. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996;335:453-461.
3. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
4. Barrett-Connor E, Laakso M. Ischaemic heart disease risk in postmenopausal women: effect of estrogen use on glucose and insulin levels. Arteriosclerosis. 1990;10:531-534.
5. Scarabin PY, Plu-Bureau G, Bora L, Bonithan-Kopp C, Giuze L, Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost. 1993;70:584-587.
6. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619-626.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;326:801-809.
8. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
9. Gilligan DM, Quyyumi A, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
10. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471-476.
11. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452-457.
12. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med. 1992;117:1038-1041.
13. Lobo RA, Pickar JH, Wild RA, Walsh BW, Hirvonen E. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol. 1994;84:173-179.
14. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991;261:R1022-R1027.
15. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter D, Miller OI, Sullivan I, Lloyd JK, Deanfield JE. Non-invasive detection of early endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:111-116.
16. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease. Ann Intern Med. 1976;85:447-452.
17. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
18. Rosenberg L, Armstrong B, Jick H. Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med. 1976;294:1256-1259.
19. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981;1:858-860.
20. Bing RJ, Conforto A. Reversal of acetylcholine effect on atherosclerotic coronary arteries by estrogen: pharmacologic phenomenon of clinical importance? J Am Coll Cardiol. 1992;20:458-459.
21. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharm Exp Ther. 1988;244:19-22.
22. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
23. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent. flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
24. Rudd MA, Loscalzo J. Estrogen and progesterone therapy has differential effects on platelet and endothelial function. Circulation. 1995;92(suppl I):I-107. Abstract.
25. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;24:1757-1761.
26. McCrohon JA, Adams MR, McCredle RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol (Oxf). 1996;45:435-441.
27. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and noresthisterone acetate. Hypertension. 1995;25:848-853.
28. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Trial. JAMA. 1995;273:199-208.
29. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
30. Haarbo J, Leth-Jespersen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progesterone replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
31. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995;92:1094-1100.
32. Celermajer DS, Sorensen KE, Georgakoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking causes dose-dependent and potentially reversible endothelial function in healthy young subjects. Circulation. 1993;88:2149-2155.
33. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular mortality in women over 50. N Engl J Med. 1985;313:1038-1043.
34. Herrington DM, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 1994;73:951-952.
35. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP. Cardiovascular disease in women. Circulation. 1993;88:1999-2009.
36. Sorensen KE, Kristensen IB, Celermajer DS. Atherosclerosis in the human brachial artery. J Am Coll Cardiol. 1997;29:318-322.
37. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
38. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
39. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. B Heart J. 1995;74:247-253.
40. Egeland GM, Kuller LH, Matthews KA, Kelsey SF, Cayley J, Guzick D. Premenopausal determinants of menopausal estrogen use. Prev Med. 1991;20:343-349.
41. Colditz GA, Stampfer MJ, Willett WC, Hennekens CH, Rosner B, Speizer FE. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 1990;264:2648-2653.